Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004).
暂无分享，去创建一个
M. Nishimura | H. Dosaka-akita | T. Kojima | T. Harada | S. Oizumi | H. Takagi | Songji Zhao | M. Higuchi | Hiroyuki Suzuki | Takuya Inoue | H. Isobe | M. Harada | Y. Fujita | H. Nishihara | H. Yokouchi | R. Kanno | J. Osugi | Koji Nakamura | Y. Matsumura | Masayuki Watanabe | H. Mine | Y. Ozaki | S. Muto | Naoyuki Okabe | T. Hasegawa | Yutaka Shio | K. Takamura | S. Yamazaki | F. Sugaya | Y. Minami | J. Sakakibara‐Konishi | A. Inano | M. Hoshino | Takumi Yamaura | Mitsuro Fukuhara | H. Kikuchi | K. Akie | O. Honjo | H. Yamaguchi | M. Aoki | Chengbo Tan | S. Shimoyama | Y. Shio | M. Watanabe | N. Okabe | J. Sakakibara-Konishi | Yoshinori Minami